Agencies, cooperative groups and societies at ENA 2026

Nov 18–20, 2026 Barcelona, Spain ~1.5k attendees Website

6 agencies, cooperative groups and societies are at ENA 2026 — 14 presentations on the program and 2 with a booth in the exhibit hall. Most represented: National Cancer Institute (NCI) (5 on the program), European Organisation for Research and Treatment of Cancer (EORTC) (2 on the program), Finnish Medicines Agency (Fimea) (1 on the program). As of Oct 13, 2026.

All 254 organizations at ENA 2026 →

Showing 1–6 of 6 organizations

Organization	ENA 2026 Attendance
National Cancer Institute (NCI) Bethesda, Maryland
cancer.gov Agencies, groups & societies Federal agency within NIH that funds and conducts cancer research, including intramural labs and clinical trials.	Session Wed Nov 18 1:30–1:35pm Opening Ceremony: Welcome and opening of the ENA 2026 Symposium Poster Wed Nov 18 12–1:30pm 3:50–4:15pm 5:45–7pm Part of Poster session: Drug Resistance and Modifiers Comparison of CRISPR screens in two- and three-dimensional ovarian cancer models to identify architecture-dependent mechanisms of resistance to CHEK1 inhibition Targeted agents Session Thu Nov 19 10–11:30am Plenary Session 3: Proffered Papers Session Thu Nov 19 5–6:30pm Workshop 6: Tumour microenvironment Immuno-oncology Poster Thu Nov 19 9:30–10am 1–3pm 4:30–5pm Part of Poster session: New therapies in immuno oncology A novel virus-like drug conjugate for the treatment of cutaneous melanoma Immuno-oncology Session Fri Nov 20 8–9:30am Plenary Session 5: Next-generation cell therapies (CAR-T, TCR) Cell therapy Session Fri Nov 20 11:15am–12pm Keynote lecture: Immunotherapy innovations Immuno-oncology Poster Fri Nov 20 10:45–11:15am 1:30–3pm Part of Poster session: Combination Therapies ClpP Agonist-Induced Cellular Senescence Promotes Vulnerability to Apoptosis and Ferroptosis in Triple Negative Breast Cancers Targeted agents
European Organisation for Research and Treatment of Cancer (EORTC) Brussels, Belgium
eortc.org Agencies, groups & societiesExhibitor Non-profit that runs multinational academic cancer clinical trials and co-organizes this symposium.	Booth Exhibiting at Booth 17–20 Wed, Nov 1812–7pmThu, Nov 199am–5:30pmFri, Nov 209am–3pm Session Wed Nov 18 10am–12pm Clinical Trial Methodology Workshop: To validate or not to validate: what is the question? Early clinical Talk Wed Nov 18 10–10:10am Part of Clinical Trial Methodology Workshop: To validate or not to validate: what is the question? Welcome Early clinical Talk Wed Nov 18 10:10–10:25am Part of Clinical Trial Methodology Workshop: To validate or not to validate: what is the question? Introduction: what is validation and why do we need it? Early clinical
Finnish Medicines Agency (Fimea) Kuopio, Finland
fimea.fi Agencies, groups & societies Finland's national medicines regulator.	Talk Wed Nov 18 11:25–11:40am Part of Clinical Trial Methodology Workshop: To validate or not to validate: what is the question? When is validation "good enough"? A regulatory perspective on endpoints, biomarkers, and novel methodologies Early clinical
Oslo Cancer Cluster Oslo, Norway
oslocancercluster.no Agencies, groups & societies Non-profit oncology cluster and incubator connecting hospitals, researchers and companies to speed cancer innovation.	Poster Fri Nov 20 10:45–11:15am 1:30–3pm Part of Poster session: Preclinical Models Pancreatic cancer-associated fibroblast-tumoroid coculture reveals morphological differences and altered drug sensitivity in functional precision medicine assays Preclinical models
Paul-Ehrlich-Institut Langen, Germany
pei.de Agencies, groups & societies Federal agency regulating vaccines and biomedicines, including cell and gene therapies.	Talk Fri Nov 20 8–8:20am Part of Plenary Session 5: Next-generation cell therapies (CAR-T, TCR) In Vivo CAR-T Cell therapy
American Association for Cancer Research (AACR) Philadelphia, PA
aacr.org Agencies, groups & societiesExhibitor Professional society for cancer research that publishes journals, holds scientific meetings and co-organizes this symposium.	Booth Exhibiting at Booth 5–6 Wed, Nov 1812–7pmThu, Nov 199am–5:30pmFri, Nov 209am–3pm